The CEO of the independent healthcare agency discusses growing a business in digital in the early 2000s and the perks of remaining independent.
Sigurdsson is charged with leading the agency's digital offering to meet growing client demand.
Pharma looks to Spark for pricing blueprint; Ipsen hires Amgen exec as CEO of North America; FDA could improve social-media approach, study finds
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
A plea for IT interoperability and a stinging criticism of the pharma industry over its lack of diversity were two highlights of yesterday's events.
How drugmakers should prepare for and respond to the forces poised to reshape the industry was a popular topic on day one of the 36th annual JP Morgan Healthcare Conference.
Celgene to buy Impact Biomedicines for up to $7 billion; Pfizer plans to cut 300 positions in neuroscience; Perrigo hires new CEO
The agency issue, people moves, and a series of restructures top the list.
VP of investor relations Teri Loxam will take over Ambrose's role in January.
The drugmaker named William Huyett as COO and Gina Consylman as SVP and CFO.
Whatever REDUCE-IT ultimately reveals (results from the completed study are expected in Q2 or Q3 2018), Salyer maintains Amarin has "a great story to tell, with or without the data."
Publicis Groupe has named Alan Wexler as chief executive of Publicis.Sapient as Chip Register has chosen to retire at the end of the year.
The CEO's experience launching medical reference app Epocrates led him to found a social network for physicians.
FDA approves first digital pill; biotech companies race to develop cancer-fighting microbiome drugs; Loxo and Bayer reach $1.55 billion deal for rare cancer drugs
Ty Curran, previously CEO of the sister agencies, will serve as chairman in 2018.
Midway through Campaign's audience with Publicis Groupe's Maurice Lévy, a heavily French-accented voice exclaims, "Now it is time for the real boss to arrive."
Trade group PhRMA's CEO talks about his first year in the job amid public outrage about price gouging.
The successes of these pharma execs show that there's no one path to professional bliss.
Management turnover has brought the opportunity to keep up the pressure.
A "seat at the table" isn't enough, says Oath's Allison Allen, in wide-ranging discussion at annual diversity conference.
Guidemark Health's Tina Fascetti offers Medela's Katie Busse advice on being a working mother in healthcare marketing.
Tony Kingsley will oversee the company's daily operations and commercial activities.
Pearson to be replaced at Valeant; Pfizer's Xeljanz meets Phase III goals; Harvard partners with Merck on leukemia drug development
By thinking like marketers, chief medical officers can embrace innovation and differentiate their organizations by providing better experiences, better products and ultimately better health.